Literature DB >> 4811763

Some negative aspects of state health departments' policies related to screening for sickle cell anemia.

I M Rutkow, J M Lipton.   

Abstract

Entities:  

Keywords:  Genetics and Reproduction

Mesh：

Year:  1974        PMID： 4811763      PMCID： PMC1775418          DOI： 10.2105/ajph.64.3.217

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  11 in total

1.  Sickle cell anemia: national program raises problems as well as hopes.

Authors:  B J Culliton
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

2.  Sickle cell anemia: the route from obscurity to prominence.

Authors:  B J Culliton
Journal:  Science       Date:  1972-10-13       Impact factor: 47.728

3.  Sickle-cell programming--an imperiled promise.

Authors:  C F Whitten
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

4.  Frequency and nature of sickling disorders.

Authors: 
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

5.  Ethical and social issues in screening for genetic disease.

Authors: 
Journal:  N Engl J Med       Date:  1972-05-25       Impact factor: 91.245

6.  Genetic counseling in sickle cell anemia and other hemoglobin disorders.

Authors:  R B Scott
Journal:  Va Med Mon (1918)       Date:  1972-05

7.  Hazards of indiscriminate screening for sickling.

Authors:  E Beutler; D R Boggs; P Heller; A Maurer; A G Motulsky; T W Sheehy
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

8.  Need to identify sickle-cell trait.

Authors:  M S Greenberg
Journal:  N Engl J Med       Date:  1970-03-12       Impact factor: 91.245

9.  Screening for sickle-cell trait and G-6-PD deficiency.

Authors:  W C Mentzer; B H Lubin; D G Nathan
Journal:  N Engl J Med       Date:  1970-05-14       Impact factor: 91.245

10.  Health care priority and sickle cell anemia.

Authors:  R B Scott
Journal:  JAMA       Date:  1970-10-26       Impact factor: 56.272
View more
  9 in total

1.  Stigmatization of carrier status: social implications of heterozygote genetic screening programs.

Authors:  R H Kenen; R M Schmidt
Journal:  Am J Public Health       Date:  1978-11       Impact factor: 9.308

2.  Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood.

Authors:  P T Rowley; L Fisher; M Lipkin
Journal:  Am J Hum Genet       Date:  1979-11       Impact factor: 11.025

3.  Education, consent, and counseling in sickle cell screening programs: report of a survey.

Authors:  M R Farfel; N A Holtzman
Journal:  Am J Public Health       Date:  1984-04       Impact factor: 9.308

4.  Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia.

Authors:  A Cao; M Furbetta; R Galanello; M A Melis; A Angius; A Ximenes; C Rosatelli; R Ruggeri; M Addis; T Tuveri; A M Falchi; E Paglietti; M T Scalas
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

5.  Management of sickle-cell disease.

Authors:  J Stuart
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

6.  A policy impact analysis of the mandatory NCAA sickle cell trait screening program.

Authors:  Beth A Tarini; Margaret Alison Brooks; David G Bundy
Journal:  Health Serv Res       Date:  2011-12-08       Impact factor: 3.402

Review 7.  Ethical issues with newborn screening in the genomics era.

Authors:  Beth A Tarini; Aaron J Goldenberg
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-05-01       Impact factor: 8.929

8.  Some influences on public participation in a genetic screening program.

Authors:  M H Becker; M M Kaback; I M Rosenstock; M V Ruth
Journal:  J Community Health       Date:  1975

9.  Acceptance of premarital health counseling in riyadh city, 1417h.

Authors:  N H Al-Kahtani
Journal:  J Family Community Med       Date:  2000-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.